It is actually concluded that EAM-2201 has the possible to trigger in vivo pharmacokinetic drug interactions when co-administered with substrates of CYP2C8, CYP3A4 and UGT1A3, and is also evaluated in pooled human liver microsomes. EAM-2201 was incubated with human hepatocytes for 3 h in a CO2 incubator as well as https://miloexlao.bloguetechno.com/eam-2201-fundamentals-explained-66405617